PLC and CardioGenesis settle patent litigation and agree financial terms over TMR procedures
This article was originally published in Clinica
Executive Summary
PLC Systems and CardioGenesis have settled all patent litigation relating to PLC's heart-synchronised laser technology for use in transmyocardial revascularisation procedures (TMR).